Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 6-K

HELIX BIOPHARMA CORP

SEC Filing

Filed May 8, 2012Accepted May 7, 2012, 3:53 PM EDTCIK 1305591Accession 0001176256-12-000312
Share

Company context

Historical securities (2)

Recent company filings

  1. 15F-12G filingJul 19, 2012
  2. F-10POS filingJul 19, 2012
  3. 25 filingJul 9, 2012
  4. 6-K filingJul 5, 2012
  5. 6-K filingJun 27, 2012

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗